H-Source Subsidiary Appoints U.S. VP’s of Sales

Spotlight Companies  |

H-Source Holdings Ltd. (CSE:HSI), a private marketplace for hospitals and surgery centers to buy and sell medical products and equipment with each other, announced today that Ashlea Souffrou has joined H-Source Inc., H-Source Holdings Ltd.'s wholly owned operating subsidiary, as VP of sales, U.S. west, and that Cori Hahn has also joined the subsidiary as VP of sales, U.S. east. Both Souffrou and Hahn will play a key role in building the sales teams, growing and servicing customers, and developing strategic partnerships nationally.

"We are excited to have them join H-Source,” said Murray Walden, President and Director of H-Source. “Both Cori and Ashlea have worked extensively in key areas of hospital and ASC (Ambulatory Surgery Center) supply chains and are also very passionate about reducing healthcare costs and supporting sustainability. They have earned the trust and respect of a significant number of hospitals and surgery centers which we believe H-Source can build on to continue to provide positive solutions."

Providing hospitals and ASCs access to medical devices, pharmaceuticals and capital equipment where members can easily perform transactions and save money, The H-Source network is a cloud-based marketplace where hospitals and ambulatory surgery centers can buy and sell excess inventory supplies and capital equipment.

Last year, the company released version 2.5 of their marketplace software. With this release, the company is focusing more resources on sales and marketing activities to increase support for current members while moving forward implementing the platform to a backlog of newly committed members as well as signing up new hospitals and medical facilities, expanding both inventory listings and member hospitals. Currently, H-Source has more than 40 medical facilities as part of their marketplace network. Furthermore, H-Source began trading on the CSE last October.

H-Source’s newly appointed VP’s of sales, along with the recent launch of their updates marketplace software, have positioned the company to successfully target and engage more than 10,000 United States hospitals and surgery centers and more than 30,000 global hospitals and surgery centers. "These are two high quality and experienced professionals who share our vision to make a difference in health care and we could not be more pleased that they decided to join us,” said John Kupice, CEO and Director of H-Source. They will make a positive impact on H-Source immediately."

For more information about H-Source, visit www.h-source.com.

Disclosure: In the purview of Section 17(B) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that Equities.com, Inc. may be compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. Equities.com is not a registered broker, broker dealer, investment advisor, analyst, investment banker or underwriter. All profiles are based on information that is available to the public. The information contained herein should not be considered to be all-inclusive and is not guaranteed by Equities.com to be free from misstatement or errors. Readers are reminded to do their own due diligence when researching any companies mentioned on this website.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer



Symbol Last Price Change % Change










Q BioMed CEO provides a Corporate Update

Denis Corin, CEO of Q BioMed Inc. ”Q“, a biomedical acceleration and development company, focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides a corporate update. Mr. Corin discusses the company's recent acquisition of Metastron, a radiopharmaceutical for cancer bone pain. Q BioMed is dedicated to providing these target assets; strategic resources, developmental support, and expansion capital to ensure they meet their developmental potential, enabling them to provide products to patients in need?.

Emerging Growth

MGX Minerals Inc.

MGX Minerals is a diversified Canadian mining company listed on the Canadian Securities Exchange. MGX is engaged in the acquisition and development of industrial mineral deposits in western Canada that…